FY2025 · period end Dec '25 · from the 10-K filed Feb 11, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $23.09B | $15.22B | $12.55B | $12.62B | $10.88B |
| Gross Profit | $8.52B | $5.14B | $4.08B | $4.03B | $3.40B |
| Operating Income | $5.87B | $3.16B | $2.56B | $2.59B | $2.11B |
| Net Income | $4.27B | $2.42B | $1.93B | $1.90B | $1.59B |
| EPS (Diluted) | $3.34 | $1.92 | $1.55 | $1.53 | $2.54 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $36.24B | $21.44B | $16.53B | $15.33B | $14.68B |
| Total Liabilities | $22.73B | $11.58B | $8.10B | $8.23B | $8.30B |
| Stockholders' Equity | $13.50B | $9.85B | $8.40B | $7.07B | $6.36B |
| Cash & Equivalents | $11.13B | $3.32B | $1.48B | $1.37B | $1.20B |
| Total Debt | $14.56B | $6.48B | $3.98B | $4.58B | $4.80B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.37B | $2.81B | $2.53B | $2.17B | $1.54B |
| Capital Expenditures | $1.00B | $0.67B | $0.37B | $0.38B | $0.36B |
| Free Cash Flow | $4.38B | $2.15B | $2.16B | $1.79B | $1.18B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 36.9% | 33.8% | 32.5% | 31.9% | 31.3% |
| Operating Margin | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% |
| Return on Equity | 36.6% | 26.6% | 24.9% | 28.3% | 26.9% |
| Return on Assets | 14.8% | 12.8% | 12.1% | 12.7% | 11.8% |
| Debt / Equity | 1.08× | 0.66× | 0.47× | 0.65× | 0.75× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001104659-26-091969 | Aug 6, 2026 | Aug 6, 2026 | Aug 6, 2026 20:01 UTC | EDGAR |
| 10-Q | 0001104659-26-089194 | Jun 30, 2026 | Jul 31, 2026 | Jul 31, 2026 20:01 UTC | EDGAR |
| 8-K | 0001104659-26-087904 | Jul 29, 2026 | Jul 29, 2026 | Jul 29, 2026 14:26 UTC | EDGAR |
| 8-K | 0001104659-26-065682 | May 21, 2026 | May 22, 2026 | May 22, 2026 20:01 UTC | EDGAR |
| 8-K | 0001104659-26-059404 | May 12, 2026 | May 12, 2026 | May 12, 2026 20:15 UTC | EDGAR |
| 8-K | 0001104659-26-055888 | May 5, 2026 | May 6, 2026 | May 6, 2026 10:30 UTC | EDGAR |
| 10-Q | 0001104659-26-054128 | Mar 31, 2026 | May 1, 2026 | May 1, 2026 20:09 UTC | EDGAR |
| 8-K | 0001104659-26-050984 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 13:05 UTC | EDGAR |
Direct links to SEC EDGAR. APH has additional filings available on the SEC site.
6 numbers AMPHENOL CORP /DE/ later changed — same XBRL tag, both filings linked.
Assets·As of Dec 31, 2014
Minor restatementwas$7B
Revised down in a 10-K.
Assets, Current·As of Dec 31, 2014
Minor restatementwas$3.5B
Revised down in a 10-K.
Long-term Debt, Excluding Current Maturities·As of Dec 31, 2014
Minor restatementwas$2.7B
Revised down in a 10-K.
Payments to Acquire Short-term Investments·FY 2008
Major restatementwas$2.9M
Revised up in a 10-K.
Proceeds from Lines of Credit·Q1 2010
Major restatementwas$19.6M
Revised up in a 10-Q.
Repayments of Long-term Debt·Q1 2015
Major restatementwas$1.7B
Revised down in a 10-Q.
APH is not the only one.
See every restatement we've found across the market — or get an alert the next time APH revises a number.
Restatements are detected by comparing every vintage of a fact across all of AMPHENOL CORP /DE/'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows APH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling AMPHENOL CORP /DE/ — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on APH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on APH and publish the result to your public profile.
Ask about AMPHENOL CORP /DE/
Continue in Workspace — cited answers on APH, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs